Cell selective cardiovascular biology of microsomal prostaglandin e synthase-1

Circulation

Volumn 127, Issue 2, 2013, Pages 233-243

  Chen, Lihong ^a,b   Yang, Guangrui ^a,b   Xu, Xiufeng ^c   Grant, Gregory ^a,b   Lawson, John A ^a,b   Bohlooly Y, Mohammad ^c   FitzGerald, Garret A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

endothelial cell; macrophage; mPGES 1; vascular injury; vascular smooth muscle cell

Indexed keywords

CYCLINE; PROSTAGLANDIN E SYNTHASE 1; TENASCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BLOOD VESSEL INJURY; BONE MARROW CELL; CARDIOVASCULAR FUNCTION; CELL HYPERPLASIA; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME DEFICIENCY; FEMALE; FEMORAL ARTERY; GENE DELETION; LEUKOCYTE; MACROPHAGE; MALE; MOLECULAR BIOLOGY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; SODIUM INTAKE; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; ENDOTHELIAL CELLS; FEMALE; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICROSOMES; MUSCLE, SMOOTH, VASCULAR; MYELOID CELLS; PRIMARY CELL CULTURE; SUBSTRATE SPECIFICITY; THROMBOSIS; VASCULAR DISEASES;

EID: 84872321927     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.119479     Document Type: Article

References (60)

1. Swan CE, Breyer RM. Prostaglandin E2 modulation of blood pressure ho-meostasis: studies in rodent models. Prostaglandins Other Lipid Mediat. 2011;96:10-13.
2. Fabre JE, Nguyen M, Athirakul K, Coggins K, McNeish JD, Austin S, Parise LK, FitzGerald GA, Coffman TM, Koller BH. Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest. 2001;107:603-610.
3. Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE. Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrom-bosis through platelet EP3 receptors. J Exp Med. 2007;204:311-320.
4. Wang M, Zukas AM, Hui Y, Ricciotti E, Puré E, FitzGerald GA. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci USA. 2006;103:14507-14512.
5. Ricciotti E, FitzGerald GA. Prostaglandins and infammation. Arterioscler Thromb Vasc Biol. 2011;31:986-1000.
6. Song WL, Lawson JA, Wang M, Zou H, FitzGerald GA. Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method. Meth Enzymol. 2007;433:51-72.
7. Wang M, FitzGerald GA. Cardiovascular biology of microsomal prosta-glandin E synthase-1. Trends Cardiovasc Med. 2010;20:189-195.
8. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, Carter D, Thomas NA, Durtschi BA, McNeish JD, Hambor JE, Jakobsson PJ, Carty TJ, Perez JR, Audoly LP. Impaired infammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA. 2003;100:9044-9049.
9. Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, Kawaguchi H, Ishikawa Y, Ishii T, Uematsu S, Akira S, Murakami M, Kudo I. Reduced pain hypersensitivity and infammation in mice lacking microsomal pros-taglandin e synthase-1. J Biol Chem. 2004;279:33684-33695.
10. Brenneis C, Coste O, Schmidt R, Angioni C, Popp L, Nusing RM, Becker W, Scholich K, Geisslinger G. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-defcient mice. J Cell Mol Med. 2008;12:639-648.
11. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. Cyclooxy-genases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest. 2006;116:1391-1399.
12. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, Puré E, FitzGerald GA. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneu-rysm formation. Circulation. 2008;117:1302-1309.
13. Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, Fitzgerald GA. COX-2-derived prostacyclin confers atheroprotection on female mice. Science. 2004;306:1954-1957.
14. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Law-son JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002;296:539-541.
15. Wang M, Ihida-Stansbury K, Kothapalli D, Tamby MC, Yu Z, Chen L, Grant G, Cheng Y, Lawson JA, Assoian RK, Jones PL, Fitzgerald GA. Mi-crosomal prostaglandin e2 synthase-1 modulates the response to vascular injury. Circulation. 2011;123:631-639.
16. Degousee N, Fazel S, Angoulvant D, Stefanski E, Pawelzik SC, Ko-rotkova M, Arab S, Liu P, Lindsay TF, Zhuo S, Butany J, Li RK, Au-doly L, Schmidt R, Angioni C, Geisslinger G, Jakobsson PJ, Rubin BB. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction. Circulation. 2008;117:1701-1710.
17. Vandendries ER, Hamilton JR, Coughlin SR, Furie B, Furie BC. Par4 is required for platelet thrombus propagation but not fbrin generation in a mouse model of thrombosis. Proc Natl Acad Sci USA. 2007;104:288-292.
18. Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 2000;102:75-81.
19. Hui Y, Ricciotti E, Crichton I, Yu Z, Wang D, Stubbe J, Wang M, Puré E, FitzGerald GA. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation. 2010;121:2654-2660.
20. Takakura N, Huang XL, Naruse T, Hamaguchi I, Dumont DJ, Yancopou-los GD, Suda T. Critical role of the TIE2 endothelial cell receptor in the development of defnitive hematopoiesis. Immunity. 1998;9:677-686.
21. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230:230-242.
22. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8:265-277.
23. Mosca M, Polentarutti N, Mangano G, Apicella C, Doni A, Mancini F, De Bortoli M, Coletta I, Polenzani L, Santoni G, Sironi M, Vecchi A, Mantovani A. Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils. J Leukoc Biol. 2007;82:320-326.
24. Díaz-Muñoz MD, Osma-García IC, Fresno M, Iñiguez MA. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem J. 2012;443:451-461.
25. Carmeliet P, Moons L, Collen D. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. Cardiovasc Res. 1998;39:8-33.
26. Miniati DN, Hoyt EG, Feeley BT, Poston RS, Robbins RC. Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 ki-nase inhibit graft coronary artery disease. Circulation. 2000;102(19 suppl 3):III237-III242.
27. Yamamoto K, Onoda K, Sawada Y, Fujinaga K, Imanaka-Yoshida K, Shimpo H, Yoshida T, Yada I. Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice. Cardiovasc Res. 2005;65:737-742.
28. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol. 2006;59:232-239.
29. Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension. 2000;35:1129-1134.
30. Zhu S, Xue R, Zhao P, Fan FL, Kong X, Zheng S, Han Q, Zhu Y, Wang N, Yang J, Guan Y. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice. Arterioscler Thromb Vasc Biol. 2011;31:1739-1747.
31. Blindt R, Bosserhoff AK, vom Dahl J, Hanrath P, Schrör K, Hohlfeld T, Meyer-Kirchrath J. Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. Eur J Pharmacol. 2002;444:31-37.
32. FitzGerald GA. COX-2 in play at the AHA and the FDA. Trends Pharmacol Sci. 2007;28:303-307.
33. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4-15.
34. Wang D, Patel VV, Ricciotti E, Zhou R, Levin MD, Gao E, Yu Z, Ferrari VA, Lu MM, Xu J, Zhang H, Hui Y, Cheng Y, Petrenko N, Yu Y, FitzGerald GA. Cardiomyocyte cyclooxygenase-2 infuences cardiac rhythm and function. Proc Natl Acad Sci USA. 2009;106:7548-7552.
35. Yu Y, Ricciotti E, Scalia R, Tang S Y, Grant G, Yu Z, Landesberg G, Crichton I, Wu W, Puré E, Funk CD, FitzGerald GA. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med. 2012;4:132ra154.
36. Wang M, Song WL, Cheng Y, Fitzgerald GA. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular infammatory disease. J Intern Med. 2008;263:500-505.
37. Soler M, Camacho M, Escudero JR, Iñiguez MA, Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E syn-thase. Circ Res. 2000;87:504-507.
38. Di Francesco L, Totani L, Dovizio M, Piccoli A, Di Francesco A, Salva-tore T, Pandolf A, Evangelista V, Dercho RA, Seta F, Patrignani P. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endo-thelial cells. Circ Res. 2009;104:506-513.
39. Uracz W, Uracz D, Olszanecki R, Gryglewski RJ. Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J Physiol Pharmacol. 2002;53(4 pt 1):643-654.
40. 2 in human coronary artery endothelial cells by cur-cumin. J Physiol Pharmacol. 2011;62:21-28.
41. Takemiya T, Matsumura K, Sugiura H, Yasuda S, Uematsu S, Akira S, Yamagata K. Endothelial microsomal prostaglandin E synthase-1 facilitates neurotoxicity by elevating astrocytic Ca2+ levels. Neurochem Int. 2011;58:489-496.
42. Takemiya T, Matsumura K, Sugiura H, Maehara M, Yasuda S, Uematsu S, Akira S, Yamagata K. Endothelial microsomal prostaglandin E syn-thase-1 exacerbates neuronal loss induced by kainate. J Neurosci Res. 2010;88:381-390.
43. Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17-33.
44. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59:207-224.
45. Brenneis C, Coste O, Altenrath K, Angioni C, Schmidt H, Schuh CD, Zhang DD, Henke M, Weigert A, Brüne B, Rubin B, Nusing R, Scho-lich K, Geisslinger G. Anti-infammatory role of microsomal prosta-glandin E synthase-1 in a model of neuroinfammation. J Biol Chem. 2011;286:2331-2342.
46. 2by platelet COX-1 in mice and humans. J Clin Invest. 2012;122:1459-1468.
47. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res. 2009;50 Suppl:S423-S428.
48. Fischer JW, Hawkins S, Clowes AW. Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg. 2004;40:115-122.
49. Harding P, LaPointe MC. Prostaglandin E2 increases cardiac fbroblast proliferation and increases cyclin D expression via EP1 receptor. Prosta-glandins Leukot Essent Fatty Acids. 2011;84:147-152.
50. Degousee N, Simpson J, Fazel S, Scholich K, Angoulvant D, Angioni C, Schmidt H, Korotkova M, Stefanski E, Wang XH, Lindsay TF, Ofek E, Pierre S, Butany J, Jakobsson PJ, Keating A, Li RK, Nahrendorf M, Geisslinger G, Backx PH, Rubin BB. Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction. Circulation. 2012;125:2904-2913.
51. Feldman LJ, Mazighi M, Scheuble A, Deux JF, De Benedetti E, Badier-Commander C, Brambilla E, Henin D, Steg PG, Jacob MP. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 2001;103:3117-3122.
52. Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of hepa-rin. Arterioscler Thromb Vasc Biol. 1996;16:1312-1318.
53. Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte in-tegrin Mac-1 (CD11b/CD18) reduces intimal thickening after an-gioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA. 1998;95:10134-10139.
54. Barron MK, Lake RS, Buda AJ, Tenaglia AN. Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation. 1997;96:3587-3592.
55. Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, Moerman E, Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation. 2002;106:599-605.
56. Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for infammation in vascular repair after angioplasty. J Clin Invest. 2000;105:293-300.
57. Hoch JR, Stark VK, van Rooijen N, Kim JL, Nutt MP, Warner TF. Macrophage depletion alters vein graft intimal hyperplasia. Surgery. 1999;126:428-437.
58. Yang T. Microsomal prostaglandin E synthase-1 and blood pressure regulation. Kidney Int. 2007;72:274-278.
59. Zhang DJ, Chen LH, Zhang YH, Yang GR, Dou D, Gao YS, Zhang XY, Kong XM, Zhao P, Pu D, Wei MF, Breyer MD, Guan YF. Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1. Acta Pharmacol Sin. 2010;31:1284-1292.
60. Facemire CS, Griffths R, Audoly LP, Koller BH, Coffman TM. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. Hypertension. 2010;55:531-538.